These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 15902683

  • 1. Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement-mediated lysis.
    Bohana-Kashtan O, Pinna LA, Fishelson Z.
    Eur J Immunol; 2005 Jun; 35(6):1939-48. PubMed ID: 15902683
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells.
    Paas Y, Bohana-Kashtan O, Fishelson Z.
    Immunopharmacology; 1999 May; 42(1-3):175-85. PubMed ID: 10408378
    [Abstract] [Full Text] [Related]

  • 3. Shedding of tyrosine and serine/threonine ecto-protein kinases from human leukemic cells.
    Paas Y, Fishelson Z.
    Arch Biochem Biophys; 1995 Feb 01; 316(2):780-8. PubMed ID: 7864634
    [Abstract] [Full Text] [Related]

  • 4. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP, Imagawa DK, Dankert JR, Ramm LE.
    J Immunol; 1986 May 01; 136(9):3402-6. PubMed ID: 3514758
    [Abstract] [Full Text] [Related]

  • 5. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
    Husler T, Lockert DH, Sims PJ.
    Biochemistry; 1996 Mar 12; 35(10):3263-9. PubMed ID: 8605162
    [Abstract] [Full Text] [Related]

  • 6. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.
    Pilzer D, Fishelson Z.
    Int Immunol; 2005 Sep 12; 17(9):1239-48. PubMed ID: 16091382
    [Abstract] [Full Text] [Related]

  • 7. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J, Gold D, LoVerde PT, Fishelson Z.
    Int J Parasitol; 2007 Jan 12; 37(1):67-75. PubMed ID: 17123534
    [Abstract] [Full Text] [Related]

  • 8. Increased sensitivity of early apoptotic cells to complement-mediated lysis.
    Attali G, Gancz D, Fishelson Z.
    Eur J Immunol; 2004 Nov 12; 34(11):3236-45. PubMed ID: 15368275
    [Abstract] [Full Text] [Related]

  • 9. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
    Guo B, Ma ZW, Li H, Xu GL, Zheng P, Zhu B, Wu YZ, Zou Q.
    Clin Immunol; 2008 Aug 12; 128(2):155-63. PubMed ID: 18502181
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
    Müller-Eberhard HJ, Zalman LS, Chiu FJ, Jung G, Martin DE.
    J Rheumatol Suppl; 1987 Jun 12; 14 Suppl 13():28-34. PubMed ID: 3612651
    [Abstract] [Full Text] [Related]

  • 11. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J, Chonn A, Hertig S, French LE.
    J Immunol; 1993 Aug 15; 151(4):2159-65. PubMed ID: 8345200
    [Abstract] [Full Text] [Related]

  • 12. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
    Vilk G, Weber JE, Turowec JP, Duncan JS, Wu C, Derksen DR, Zien P, Sarno S, Donella-Deana A, Lajoie G, Pinna LA, Li SS, Litchfield DW.
    Cell Signal; 2008 Nov 15; 20(11):1942-51. PubMed ID: 18662771
    [Abstract] [Full Text] [Related]

  • 13. CK2-mediated phosphorylation of a type II regulatory subunit of cAMP-dependent protein kinase from the mollusk Mytilus galloprovincialis.
    Bardales JR, Hellman U, Villamarín JA.
    Arch Biochem Biophys; 2007 May 01; 461(1):130-7. PubMed ID: 17379180
    [Abstract] [Full Text] [Related]

  • 14. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D, Donin N, Fishelson Z.
    Mol Immunol; 2009 Dec 01; 47(2-3):310-7. PubMed ID: 19864026
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2.
    Bone DB, Robillard KR, Stolk M, Hammond JR.
    Mol Membr Biol; 2007 Dec 01; 24(4):294-303. PubMed ID: 17520485
    [Abstract] [Full Text] [Related]

  • 16. Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action.
    Olsen BB, Bjørling-Poulsen M, Guerra B.
    Int J Biochem Cell Biol; 2007 Dec 01; 39(1):227-37. PubMed ID: 17018259
    [Abstract] [Full Text] [Related]

  • 17. Detection of refolding conformers of complement protein C9 during insertion into membranes.
    Laine RO, Esser AF.
    Nature; 1989 Sep 07; 341(6237):63-5. PubMed ID: 2475785
    [Abstract] [Full Text] [Related]

  • 18. Resorufin: a lead for a new protein kinase CK2 inhibitor.
    Sandholt IS, Olsen BB, Guerra B, Issinger OG.
    Anticancer Drugs; 2009 Apr 07; 20(4):238-48. PubMed ID: 19177021
    [Abstract] [Full Text] [Related]

  • 19. Laminin-1 is phosphorylated by ecto-protein kinases of monocytes.
    Trachana V, Christophorides E, Kouzi-Koliakos K, Koliakos G.
    Int J Biochem Cell Biol; 2005 Feb 07; 37(2):478-92. PubMed ID: 15474991
    [Abstract] [Full Text] [Related]

  • 20. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
    Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, Bain J, Elliott M, Meggio F, Kazimierczuk Z, Pinna LA.
    J Med Chem; 2004 Dec 02; 47(25):6239-47. PubMed ID: 15566294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.